October 2016

New Contraindications

Kaletra (lopinavir/ritonavir) should not be coadministered concurrently with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life threatening events including colchicine in patients with renal and/or hepatic impairment and dronedarone.

Ketoral (ketorolac trometamol) is now also contraindicated in those undergoing treatment of perioperative pain in setting of coronary artery surgery (CABG) and those with severe hepatic impairment.

Parnate (tranylcypromine sulfate) is now contraindicated with nefopam; in patients with known porphyria and in patients with hyperthyroidism.

Xiaflex (collagenase clostridium histolyticum) - do not use for the treatment of Peyronie’s plaques that involve the penile urethra due to potential risk to this structure.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629